Skip Ribbon Commands
Skip to main content
CIBMTR

Study Lists

Sharing knowledge. Sharing Hope.
Skip Navigation LinksHome   /   Studies   /   Clinical Outcomes Research   /   Study Lists   /   Observational Study
  • Print
  • Share

 


Recently Completed Studies

Study # MM18-04
Study Status: Published
Working Committee: Plasma Cell Disorders

Citation

Hagen P, D'Souza A, Hari P, Davila O, Zhang M-J, Vesole DH, Smith SE, Rodriguez TE, Stiff PJ. Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: Long term follow up of a novel high dose regimen. Leukemia & Lymphoma. 2020 Dec 1; 61(14):3484-3492. doi:10.1080/10428194.2020.1811275. Epub 2020 Aug 31. PMCID:PMC7786301.

Presentation(s)

2019, ASH

PubMed
PMID: 32865474
Abstract

Working Committee Contact

Omar Dávila (Unknown)
odavila@mcw.edu
Last Updated: 10/29/2010 4:55 PM
CIBMTR